Department of Pathology, Kawasaki Medical School, Kurashiki, Japan.
Mod Pathol. 2010 Mar;23(3):439-49. doi: 10.1038/modpathol.2009.194. Epub 2010 Jan 15.
The distribution and pathological significance of sphingosine-1-phosphate receptor 1 expression are still unclear. In this study, we evaluated sphingosine-1-phosphate receptor 1's suitability as a diagnostic marker for malignant lymphoma by immunostaining formalin-fixed paraffin-embedded sections using a well-defined commercial anti-sphingosine-1-phosphate receptor 1 antibody. Sphingosine-1-phosphate receptor 1 was strongly expressed on the surface of small lymphocytes forming primary lymphoid follicles and in the mantle zone of secondary lymphoid follicles. Microarray-based immunohistochemistry with tissue samples from 85 lymphoid malignancy cases demonstrated that sphingosine-1-phosphate receptor 1 was expressed on the surface of mantle cell lymphoma cells. Strong expression was observed in all classical mantle cell lymphoma cases involving the lymph node (19 out of 19), gastrointestinal tract (10 out of 10), bone marrow (9 out of 9), and orbita (1 out of 1). Good results were obtained even in sections where cyclin D1 signals were lost because of over-fixation and/or decalcification. One aggressive variant of mantle cell lymphoma displayed a weaker membranous staining than classical mantle cell lymphoma in the lymph node and bone marrow. In a cyclin D1-negative mantle cell lymphoma of the orbita, no conclusive result was obtained. No cases of follicular lymphoma, marginal zone lymphoma, B lymphoblastic leukemia/lymphoma, or Burkitt's lymphoma showed any significant expression, whereas 2 out of 6 chronic lymphocytic leukemia/small lymphocytic lymphomas in bone marrow, 1 out of 3 lymphoplasmacytic lymphomas in the lymph node, and 2 out of 37 diffuse large B-cell lymphomas exhibited staining. A quantitative reverse transcription polymerase chain reaction-based analysis of mantle cell lymphoma lines revealed the sphingosine-1-phosphate receptor 1 mRNA expression level to be well correlated with the results of immunocytochemistry, flow cytometry, and western blotting. Thus, sphingosine-1-phosphate receptor 1 immunohistochemistry may be useful in the histological diagnosis of mantle cell lymphoma with formalin-fixed and paraffin-embedded sections. The antigen may be particularly valuable in cases where cyclin D1 immunostaining is not successful.
Sphingosine-1-phosphate receptor 1 的分布和病理意义尚不清楚。在这项研究中,我们使用一种经过明确定义的商业抗鞘氨醇-1-磷酸受体 1 抗体,通过对福尔马林固定石蜡包埋切片进行免疫染色,评估鞘氨醇-1-磷酸受体 1 作为恶性淋巴瘤诊断标志物的适用性。鞘氨醇-1-磷酸受体 1 在形成初级淋巴滤泡的小淋巴细胞表面和次级淋巴滤泡的套区强烈表达。使用 85 例淋巴恶性肿瘤病例的组织样本进行基于微阵列的免疫组织化学分析表明,鞘氨醇-1-磷酸受体 1 表达在套细胞淋巴瘤细胞的表面。在所有涉及淋巴结(19 例中的 19 例)、胃肠道(10 例中的 10 例)、骨髓(9 例中的 9 例)和眼眶(1 例中的 1 例)的经典套细胞淋巴瘤病例中均观察到强表达。即使在因过度固定和/或脱钙而丢失 cyclin D1 信号的切片中,也获得了良好的结果。一种侵袭性套细胞淋巴瘤变体在淋巴结和骨髓中的膜染色比经典套细胞淋巴瘤弱。在眼眶中的 cyclin D1 阴性套细胞淋巴瘤中,未获得明确结果。滤泡性淋巴瘤、边缘区淋巴瘤、B 淋巴母细胞性白血病/淋巴瘤或伯基特淋巴瘤均未见明显表达,而骨髓中的 6 例慢性淋巴细胞白血病/小淋巴细胞淋巴瘤中的 2 例、淋巴结中的 3 例淋巴浆细胞淋巴瘤中的 1 例和 37 例弥漫性大 B 细胞淋巴瘤中的 2 例显示染色。套细胞淋巴瘤系的定量逆转录聚合酶链反应分析显示,鞘氨醇-1-磷酸受体 1 mRNA 表达水平与免疫细胞化学、流式细胞术和 Western blot 结果高度相关。因此,鞘氨醇-1-磷酸受体 1 免疫组织化学可能有助于福尔马林固定和石蜡包埋切片的套细胞淋巴瘤的组织学诊断。在 cyclin D1 免疫染色不成功的情况下,该抗原可能特别有价值。